“invivodata has a great team. Having worked with them before, I have been very impressed with invivodata’s strength as the industry’s leading provider of ePRO data," Summa said.
Pittsburgh, PA (PRWEB) October 25, 2011
invivodata inc.®, the industry leader in patient reported outcomes (PRO) solutions and services for global clinical research, today announced the appointment of Dr. Wolfgang Summa as Vice President of Worldwide Operations. Working out of invivodata’s headquarters in Pittsburgh, Summa will be responsible for managing the successful implementation of invivodata’s ePRO solutions in clinical trials around the world. He rejoins the company after having previously served as Vice President of Europe and Asia.
Dr. Summa brings more than 15 years of Clinical Research experience to invivodata’s growing worldwide operations team. He has significant experience in the operational management of new eClinical technologies and their resulting process changes, including electronic data capture, ePRO, and eLearning solutions. Additionally, he is currently serving his second term on the Clinical Data Interchange Standards Consortium (CDISC) European Coordinating Committee.
“We are thrilled to welcome Wolfgang back to invivodata’s senior management team,” said Bob Young, Chief Operating Officer at invivodata. “We are fortunate to have someone with such broad clinical research and operational management experience lead our team of dedicated professionals who are committed to delighting our expanding global customer base.”
Summa’s appointment comes as invivodata recognizes significant growth in the worldwide adoption of DiaryPRO® and SitePRO®, its field-based and site-based ePRO solutions. Since Q1, 2010, invivodata has seen record growth in bookings from biopharmaceutical and medical device companies. To meet growing market demand, invivodata has grown its global operational employee headcount by 80% and expanded its Pittsburgh headquarters by nearly 50%.
“invivodata has a great team. Having worked with them before, I have been very impressed with invivodata’s strength as the industry’s leading provider of ePRO data,” Summa said. “I look forward to joining the operations team during this time of exciting growth and further expanding invivodata’s global presence by continuing to deliver on its commitment to the highest levels of customer service.”
invivodata is the only fully-integrated PRO Solutions Organization delivering regulatory-proven strategic consulting and practical ePRO solutions to biopharmaceutical companies who depend upon patient-centered research. From crafting PRO measurement strategy to collecting PRO data electronically, invivodata helps its customers strategically use patient reported data to support labeling claims, enhance market access, and meet other clinical program objectives. Through partnerships with leading CROs and eClinical technology providers, invivodata seamlessly integrates into the clinical trial ecosystem, helping to minimize operational risk and maximize efficiencies. invivodata’s solutions have been used in over 350 clinical programs and are built upon the industry-leading ePRO system in delivering primary efficacy data for global drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, PA., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, CA., USA. For more information, visit http://www.invivodata.com.